Inicio › Mieloma múltiple › Pensilvania

Ensayos clínicos de Mieloma múltiple en Pensilvania

24 estudios sobre Mieloma múltiple buscan participantes en Pensilvania.

Ciudades en Pensilvania

Texto oficial del estudio (inglés)

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

ECOG-ACRIN Cancer Research Group, Philadelphia

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06948084

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine, Philadelphia

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05652335

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

University of Pennsylvania, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh

ReclutandoFase 4

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT05201781

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Thomas Jefferson University Hospital, Philadelphia
Fox Chase Cancer Center, Philadelphia

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07258511

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Penn State Milton S Hershey Medical Ctr, Hershey
Allegheny Health Network, Pittsburgh

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT05552222

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

Penn Medicine, Philadelphia

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07116616

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lehigh Valley Hospital - Cedar Crest, Allentown
Lehigh Valley Hospital- Muhlenberg, Bethlehem
Pocono Medical Center, East Stroudsburg
y 2 más

ReclutandoFase 2

Edades de 12 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT02693535

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Penn State Hershey Medical Center, Hershey

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07648264

Collection of Tissue Samples for Cancer Research

University of Pittsburgh Medical Center, Pittsburgh

ReclutandoEstudio observacional

2 Months · Todos los sexos · Actualizado el 16 sept 2026 · NCT00900198

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

AHN West Penn Hospital, Pittsburgh

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT06297226

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

AHN West Penn Hospital, Pittsburgh

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT06152575

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Pocono Medical Center, East Stroudsburg
y 3 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT04566328

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

Research Site, Philadelphia

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT06106945

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

University of Pennsylvania, Philadelphia

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT05651932

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

ECOG-ACRIN Cancer Research Group, Philadelphia

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 ago 2026 · NCT07463807

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Penn Medicine - Abramson Cancer Center Perelman, Philadelphia

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jun 2026 · NCT04068597

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Geisinger Medical Center, Danville
y 5 más

ReclutandoFase 3

Todas las edades · Todos los sexos · Actualizado el 10 jun 2026 · NCT05561387

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

University of Pennsylvania/Abramson Cancer Center, Philadelphia

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 jun 2026 · NCT03858205

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Lehigh Valley Health Network, Allentown
Penn Medicine Lancaster General, Lancaster
Abramson Cancer Center University of Pennsylvania Medical Center, Philadelphia
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 jun 2026 · NCT05243797

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Allegheny Health Network, Pittsburgh

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 24 mar 2026 · NCT04988555

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

Thomas Jefferson University Hospital, Philadelphia

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 nov 2025 · NCT07188090

Two Step Haplo With Radiation Conditioning

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadephia

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2025 · NCT05031897

Limited-duration Teclistamab

Abramson Cancer Center at University of Pennsylvania, Philadelphia
Thomas Jefferson University, Honickman Center, Philadelphia

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2025 · NCT05932680

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.